CSTL Live signals | Maximize Profits with Getagraph.com

SELL 95392 min ago

@ $23.12

Issued: 13 Feb 2024 @ 12:40

Return: -16.48%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -2.45 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers...

Stats
Today's Volume	118 988
Average Volume	237 793
Market Cap	530.06M
EPS	$0 ( 2024-02-28 )
Next earnings date	( $-0.370 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.02
ATR14	$0.0290 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-12	Maetzold Derek J	Sell	997	Common Stock
2024-04-12	Maetzold Derek J	Sell	997	Common Stock
2024-04-12	Maetzold Derek J	Sell	1 947	Common Stock
2024-04-12	Maetzold Derek J	Sell	318	Common Stock
2024-04-12	Maetzold Derek J	Sell	317	Common Stock

INSIDER POWER
32.18
Last 99 transactions
Buy: 329 657 \| Sell: 173 929

Volume Correlation

Long: 0.31 (neutral)

Short: 0.63 (weak)

Signal:(67.377) Neutral

Castle Biosciences Inc Correlation

10 Most Positive Correlations
ATHN	0.922
BOCH	0.887
ONCR	0.881
TLRY	0.88
SOPA	0.874
KSPN	0.867
GBRG	0.854
PHCF	0.853
RAIN	0.847
THCB	0.844

10 Most Negative Correlations
AVGO	-0.912
IKT	-0.906
BWC	-0.903
ANY	-0.903
KRUS	-0.901
ADVM	-0.894
GAINL	-0.893
ACLS	-0.891
MOTNU	-0.878
PCYG	-0.875

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Castle Biosciences Inc Correlation - Currency/Commodity

0.16
( neutral )

0.46
( neutral )

0.00
( neutral )

-0.31
( neutral )

0.21
( neutral )

0.17
( neutral )

Castle Biosciences Inc Financials

Annual	2023
Revenue:	$219.79M
Gross Profit:	$164.23M (74.72 %)
EPS:	$-2.14

Q4	2023
Revenue:	$66.12M
Gross Profit:	$51.03M (77.17 %)
EPS:	$-0.0954

Q3	2023
Revenue:	$61.49M
Gross Profit:	$50.17M (81.59 %)
EPS:	$-0.260

Q2	2023
Revenue:	$50.14M
Gross Profit:	$39.08M (77.94 %)
EPS:	$-0.700

Financial Reports:

No articles found.

Castle Biosciences Inc

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.